Chimeric antibodies are engineered antibodies that combine the variable region of a mouse antibody with the constant region of a human antibody, enhancing their compatibility with the human immune system. This design reduces immunogenicity while retaining the specificity and affinity of the original mouse antibody, making them effective for therapeutic use.